3Rs for innovating novel antibiotics: sharing resources, risks, and rewards
نویسندگان
چکیده
منابع مشابه
3Rs for innovating novel antibiotics: sharing resources, risks, and rewards.
The dearth of novel antibiotics poses challenges to the treatment of bacterial infection and points to shortcomings in the system of pharmaceutical innovation. Increasing bacterial resistance to existing antibiotics causes substantial morbidity and mortality and threatens society’s ability to realise benefits from modern medical advances. Access to effective antibiotics is essential to treating...
متن کاملA model for inter-institutional 3Rs co-operation – sharing in vivo research resources
With the broad goal of reducing and replacing research animal use where possible, MedImmune entered into an inter-institutional agreement to make ferret trachea tissue available to a neighboring academic institution so as to enable them to carry out vital in vitro research work without having to obtain additional live animals. Over the course of 3 years, MedImmune provided the Cystic Fibrosis R...
متن کاملRisks and rewards.
43 IAM HONORED to be the inaugural contributor to the Journal of Palliative Medicine series on palliative care pioneers. I look back at the path that I and many of my peers like Andy Billings, Jim Hallenbeck, Robert Arnold, Charles von Gunten, and other leaders have traveled, and I am both awed and humbled by how far we have come in such a short period of time. I was a rather typical, academica...
متن کاملResources, repositories and rewards.
Vivian Siegel is at the Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA (e-mail: [email protected]) By establishing the Resource Article section and stronger policies for materialssharing and citation, we hope to encourage and properly reward the development and sharing of resources, thereby accelerating research using model organisms to advanc...
متن کاملNew business models for antibiotic innovation
The increase in antibiotic resistance and the dearth of novel antibiotics have become a growing concern among policy-makers. A combination of financial, scientific, and regulatory challenges poses barriers to antibiotic innovation. However, each of these three challenges provides an opportunity to develop pathways for new business models to bring novel antibiotics to market. Pull-incentives tha...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 2012
ISSN: 1756-1833
DOI: 10.1136/bmj.e1782